Graduate School, Guangzhou Medical University, Guangzhou, 511436, P. R. China.
State Key Laboratory of Pathogen and Biosecurity, Beijing Institute of Microbiology and Epidemiology, Academy of Military Medical Sciences, Beijing, 100071, P. R. China.
Adv Sci (Weinh). 2024 May;11(17):e2309624. doi: 10.1002/advs.202309624. Epub 2024 Feb 26.
Mild-heat photothermal antibacterial therapy avoids heat-induced damage to normal tissues but causes bacterial tolerance. The use of photothermal therapy in synergy with chemodynamic therapy is expected to address this issue. Herein, two pseudo-conjugated polymers P with photothermal units and P with ferrocene (Fc) units are designed to co-assemble with DSPE-mPEG into nanoparticle NP. NP under 1064 nm laser irradiation (NP+NIR-II) generates mild heat and additionally more toxic ∙OH from endogenous HO, displaying a strong synergistic photothermal and chemodynamic effect. NP+NIR-II gives >90% inhibition rates against MDR ESKAPE pathogens in vitro. Metabolomics analysis unveils that NP+NIR-II induces bacterial metabolic dysregulation including inhibited nucleic acid synthesis, disordered energy metabolism, enhanced oxidative stress, and elevated DNA damage. Further, NP+NIR-II possesses >90% bacteriostatic rates at infected wounds in mice, resulting in almost full recovery of infected wounds. Immunodetection and transcriptomics assays disclose that the therapeutic effect is mainly dependent on the inhibition of inflammatory reactions and the promotion of wound healing. What is more, thioketal bonds in NP are susceptible to ROS, making it degradable with highly favorable biosafety in vitro and in vivo. NP+NIR-II with a unique synergistic antibacterial strategy would be much less prone to select bacterial resistance and represent a promising antibiotics-alternative anti-infective measure.
低热光热抗菌疗法避免了热诱导对正常组织的损伤,但会导致细菌产生耐受性。预计将光热疗法与化学动力学疗法联合使用可以解决这个问题。本文设计了两种具有光热单元的伪共轭聚合物 P 和具有二茂铁(Fc)单元的聚合物 P,与 DSPE-mPEG 共组装成纳米颗粒 NP。在 1064nm 激光照射下(NP+NIR-II),NP 产生低热,并从内源性 HO 产生更多的毒性 ∙OH,表现出强烈的协同光热和化学动力学效应。NP+NIR-II 对体外耐多药 ESKAPE 病原体的抑制率超过 90%。代谢组学分析揭示,NP+NIR-II 诱导细菌代谢失调,包括抑制核酸合成、紊乱的能量代谢、增强氧化应激和升高的 DNA 损伤。此外,NP+NIR-II 在感染伤口的小鼠中具有 >90%的抑菌率,导致感染伤口几乎完全恢复。免疫检测和转录组学分析表明,治疗效果主要取决于炎症反应的抑制和伤口愈合的促进。更重要的是,NP 中的硫代缩醛键易受 ROS 影响,使其在体外和体内具有高度良好的生物降解性和安全性。NP+NIR-II 具有独特的协同抗菌策略,不太可能导致细菌耐药性的选择,是一种很有前途的抗生素替代抗感染措施。